The German Breast Group conducts research into breast cancer, developing and implementing its own study concepts.
With the help of additional scientific research projects, we strive to gain further insights into this disease.
In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
Neue Daten zum Überleben von Brustkrebspatientinnen mit Chemotherapie während der Schwangerschaft
We are happy to present our research at the ASCO Annual meeting June 2022.
We are pleased to inform you that an exploratory analysis of the randomized phase III GrparOcto trial has been published in Cancer
Exploratory analysis of GeparOcto patients published in "Cancers"
Every month, we present an interesting paper.
We are pleased to inform you that an exploratory analysis of the randomized phase III GrparOcto trial has been published in Cancer